Table 1.
n | (%) | |||
---|---|---|---|---|
Donor | 101 | 100.0 | ||
Female/male | 74/27 | 73.3/26.7 | ||
Mean donor age | 39 ± 8.1 |
HLA mismatch | ||||
---|---|---|---|---|
Donor relationship torecipient | I class | II class | ||
All | 101 | 100.0 | 1.6 ± 0.7 | 0.9 ± 0.6 |
Parent | 83 | 82.2 | 1.5 ± 0.6 | 0.8 ± 0.5 |
Sibling | 1 | 1.0 | 0 | 0 |
Other related | 17 | 16.8 | 1.9 ± 1.0 | 1.5 ± 0.6 |
Genetically unrelated | 0 | 0.0 | ||
Recipient | 101 | 100 | ||
Diagnosis | ||||
Congenital dysplasia | 23 | 22.8 | ||
Reflux nephropathy | 29 | 28.7 | ||
FSGS | 6 | 5.9 | ||
Obstructive (valves + hydronephrosis) | 5 | 5.0 | ||
Congenital nephrotic syndrome | 4 | 4.0 | ||
HUS | 9 | 8.9 | ||
Alport syndrome | 3 | 3.0 | ||
Cystinosis | 1 | 1.0 | ||
Other diagnosis (vasculitis, TIN, cortical necrosis, Fanconi, glomerulonephritis) | 14 | 13.9 | ||
Unknown | 7 | 6.9 | ||
Female/male | 52/49 | |||
Mean recipient age | 10.7 ± 5.1 | |||
PRA > 30 | 5 | 5.0 | ||
Primary graft | 100 | 99.0 | ||
Secondary graft | 1 | 1.0 | ||
ABOi, patients no. | 8 | 7.9 | ||
Plasma exchange pre-Tx, patients no. | 6 | 75.0 | ||
Plasma exchange pre-Tx, procedures per patient no. | 1.5 ± 1.1 | |||
Isoagglutinin titer | ||||
Original | 5.8 ± 2.3 | |||
Pre-Tx | 2.3 ± 1.5 |
PRA, panel reactive antibodies.